Status:

COMPLETED

Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)

Lead Sponsor:

University of Nottingham

Collaborating Sponsors:

National Institute for Health Research, United Kingdom

Conditions:

Irritable Bowel Syndrome With Diarrhoea

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

Irritable bowel syndrome is a common condition affecting 1 in 10 of the population. About a third of these suffer from diarrhoea, which severely impairs their quality of life. Previous studies in Nott...

Eligibility Criteria

Inclusion

  • IBS-D patients meeting the Rome III criteria.
  • Male or female aged 18-75 years
  • Women of child bearing potential (who have a negative pregnancy test) must agree to use methods of medically acceptable forms of contraception during the study., (e.g. implants, injectables, combined oral contraceptives, sexual abstinence or vasectomised partners)
  • Patients who are able to give informed consent.

Exclusion

  • Women who are pregnant or breastfeeding
  • Patients that, in the opinion of the investigator, are considered unsuitable.
  • Patients who have had abdominal surgery which may cause bowel symptoms similar to IBS (Please note, appendicectomy and cholecystectomy is not an exclusion)
  • Patient unable to stop anti-diarrhoeal drugs
  • Patients currently participating in another clinical trial or who have been in a trial in the previous three months
  • Since many patients will be on SSRIs or tricyclics antidepressants these will not be an exclusion criteria, provided they have been on medication at least 3 months and that the dose remains unaltered throughout the study.

Key Trial Info

Start Date :

January 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2011

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00745004

Start Date

January 1 2009

End Date

July 1 2011

Last Update

January 24 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital of South Manchester NHS Foundation Trust

Manchester, Greater Manchester, United Kingdom, M23 9LT

2

University of Nottingham

Nottingham, Nottinghamshire, United Kingdom, NG7 2UH

Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D) | DecenTrialz